Article Details
Retrieved on: 2024-03-22 20:21:43
Tags for this article:
Click the tags to see associated articles and topics
Summary
Helge Bode's team at the Max Planck Institute utilized synthetic biology and enzyme engineering to expedite drug development, focusing on nonribosomal peptide synthetases (NRPS) to tackle drug resistance.
Article found on: www.labmanager.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here